Open AccessP1332: PROMISING OUTCOME OF PATIENTS OLDER THAN 70 YEARS WHO UNDERWENT PERIPHERAL BLOOD HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OR HIGH RISK MYELODYSPLASTIC SYNDROME
Author(s) -
Harbi S.,
Brac de la perriere L.,
Garciaz S.,
Pagliardini T.,
Calmels B.,
Cecile M.,
Hicheri Y.,
Bouchacourt B.,
Calleja A.,
Dachy F.,
Fürst S.,
Lemarie C.,
Braticevic C.,
Morel G.,
Legrand F.,
Bekrieva E.,
Granata A.,
Weiller P. J.,
Chaban C.,
Vey N.,
Blaise D.,
Devillier R.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848192.39196.d2
Subject(s) - medicine , fludarabine , transplantation , myeloid leukemia , cyclophosphamide , myelodysplastic syndromes , hematopoietic stem cell transplantation , busulfan , surgery , graft versus host disease , oncology , chemotherapy , bone marrow